Ten percent more steroids found in Scottish prisons

Researchers at the university's Leverhulme Research Centre of Forensic Science (LRCFS), part of the School of Science and Engineering, made the discovery as part of a collaboration with the Scottish Prison Service (SPS).

Their results were published in a new publication. Changing trends in anabolic and androgenic steroid use in Scottish prisonspublished by Wiley.

The researchers analyzed 3,896 suspected drug samples, all seized in Scottish prisons between January 2019 and August 2023.

Of the samples analyzed in 2019, less than one percent contained anabolic-androgenic steroids (AAS), compared to more than 10 percent in 2023.

Various types of AAS were found – and they were the third most common drug detected in Scottish prisons in 2023.

Most of these steroid medications (77 percent) were in tablet form and were available in a variety of bright colors.

AAS compounds were also found in powders, herbal material, a fragmented soap bar sample and in vaporizers. In many cases, ASA was found together with other illicit substances.

Dr Lorna Nisbet, senior lecturer at LRCFS who was involved in the study, said: “The research shows a significant increase in steroid compounds in prisons, and they are being detected in forms we would not normally expect to see them, such as plant materials and vaporizers.”

“Many of these materials contain a combination of different drugs in different amounts, making it difficult for individuals to know exactly what they are taking or in what dosage.

“When using these drugs, people may unknowingly use multiple drugs. The effects of these drugs in combination with others can be particularly problematic.”

Polydrug use – the use of more than one substance at the same time – was prevalent in 81 percent of all drug misuse deaths in 2023, new data on drug-related deaths recently released by the National Records of Scotland shows.

“Polytoxicological use can increase the toxic effects of drugs, prolong their effects on the person and increase negative side effects,” said Dr. Nisbet.

“It is important that those working in prisons are aware of the drugs that may be being used so that they can provide the necessary support and respond more effectively to emerging risks.

“This is one of the reasons we work with SPS as it has enabled rapid identification of changing drug use patterns and trends in the Scottish prison system.”

She added: “There is no routine testing for steroids in the UK, but these data suggest that their use may be increasing and that greater monitoring of these drugs may be needed.”